by Gregg A. Masters, MPH
The must be a part of healthcare investor gathering launches today in San Francisco – perhaps for the last time.
Fortunately, JP Morgan continues its tradition of inviting access and engagement in the content streamed by participating companies. In order to access the program agenda, list of participating companies, profiles, supporting decks and scheduled webcasts you need to register and agree to the terms of service stipulated by the underwriting host and principals from JP Morgan.
The portal for registration is accessible here.
The Monday morning line-up kicks off with many bellwether pharma and biotech performers including Celgene’s pending acquisition by Bristol Meyers Squibb in the convergent pharma, life sciences and biotech sectors, as well the year end results from Medicaid managed care market leader Centene (including the combined operating performance of California innovator in the HMO space, HealthNet).
There is so much to follow to gain insights on the performance of operators in the payor, provider and supplier, including medical device sectors.
Do not miss this time limited availability of material insights into the complex ecosystem of the U.S. healthcare economy.